INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING SMARCB1-DEFICIENT CANCERS"

GENEVA, Jan. 20 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/036939) for "METHODS OF TREATING SMARCB1-DEFICIENT CANCERS" on Jul 09, 2025. With publication no. WO/2026/015612, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KNORR, David (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), ULDRICK JR., Thomas S. (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591)

Ab...